Medytox

Developing botulinum toxins, synthetic drugs, supplements & medical devices

placeSeoul, Seoul, South Korea calendar_todayFounded 2000 language medytox.com

Registered entities

Investor mix

10 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital770%
Private equity110%
Accelerator & incubator110%
Bank & private debt110%
Coming soon